TAE Technologies Upgrades Norm Fusion Reactor to Underpin Commercial Development
PR Newswire
HOUSTON and FOOTHILL RANCH, Calif., Nov. 17, 2026
New fueling, beam and heating systems on Norm will carry over to Da Vinci, TAE's planned commercial demonstration plant
HOUSTON and FOOTHILL RANCH, Calif., Nov. 17, 2026 /PRNewswire/ -- TAE Technologies, an advantaged technologies company and a leading developer of commercial fusion power, today shared progress on upgrades designed to take its sixth-generation fusion reactor, Norm, from its previous 70 million degrees Celsius to 100 million degrees Celsius, the temperature threshold for deuterium-tritium (D-T) fusion.
Norm was the first fusion reactor to form, heat and sustain a Field-Reversed Configuration (FRC) plasma using only particle accelerator beams, resulting in a simpler and more cost-effective design.
TAE aims to reach 100 million degrees Celsius at fusion-relevant density and confinement in 2027, subject to installation and testing. Achieving those conditions in a linear design would demonstrate that the plasma regime underlying commercial fusion is accessible in a compact, lower-cost and easier to operate configuration — and would lay the groundwork for TAE's target fuel, hydrogen-boron (p-B11), which offers further performance and cost advantages.
From Norm to Da Vinci
Norm is the proving ground for Da Vinci, a 50 MW plant expected to validate the physics performance of TAE's approach to commercial fusion.
Fusion demands keeping plasma hot, dense and stable all at once. TAE's Norm upgrade has advanced three workstreams that further address these requirements:
- Fueling: enhanced capability for denser, longer-lasting plasma and finer control over the fuel
- Neutral beams: higher-power beams that add both heat and fuel
- Radio frequency (RF) heating: additional heat without additional fuel
"Norm is where we refine the Da Vinci design before we build it," said Michl Binderbauer, CEO and CTO of TAE Technologies. "The fueling, the beams and the heating are the systems Da Vinci will run on. Every result we get from the upgrades brings us closer to realizing commercial fusion."
While Da Vinci is targeted to demonstrate fusion energy by 2031, TAE's proprietary technology developed along the way is already being commercialized for energy storage, power management and cancer treatment.
For more information, visit TAE.com
Media contact: press@tae.com
About TAE Technologies
TAE Technologies develops and commercializes advantaged technologies for the world's most demanding scientific and engineering challenges. The company's north star is reliable and abundant fusion energy delivered as a cost-competitive component of the global energy supply. TAE's pursuit of fusion has produced technologies with commercial applications beyond electricity generation. TAE Power Solutions (TPS) applies fusion-derived, microsecond-scale power control to the rapidly fluctuating power demands of AI compute through its flagship offering, TAE PowerFabric™. TAE Life Sciences (TLS) develops proprietary boron drugs and applies TAE's particle accelerator technology to its Alphabeam™ platform for boron neutron capture therapy (BNCT), a biologically targeted treatment aiming to improve outcomes for patients with difficult-to-treat cancers.
Disclaimer
This press release contains "forward-looking statements" within the meaning of the federal securities laws, including statements regarding TAE's future business plans, and TAE's development and commercialization of fusion energy technology, including the Da Vinci prototype power plant. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including, among others: the significant capital required to develop and commercialize TAE's fusion technology; the risk that TAE may be unable to successfully develop or commercialize a viable fusion reactor on its expected timeline or at all; and other risks and uncertainties described in Trump Media & Technology Group Corp.'s filings with the SEC in connection with the proposed and previously announced merger transaction with TAE, including in TMTG's registration statement on Form S-4 and the risk factors described therein. TAE undertakes no obligation to update any forward-looking statements, except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/tae-technologies-upgrades-norm-fusion-reactor-to-underpin-commercial-development-302941442.html
SOURCE TAE Technologies, Inc.
